Literature DB >> 9379439

A model for binding of structurally diverse natural product inhibitors of protein phosphatases PP1 and PP2A.

V Gupta1, A K Ogawa, X Du, K N Houk, R W Armstrong.   

Abstract

Protein phosphatases play significant roles in signal transduction pathways pertaining to cell proliferation, gene expression, and neurotransmission. Serine/threonine phosphatases PP1 and PP2A, which are closely related in primary structure (approximately 50%), are inhibited by a structurally diverse group of natural toxins. As part of our study toward understanding the mechanism of inhibition displayed by these toxins, we have developed research in two directions: (1) The standardization of an assay to be used in acquisition of the structure--activity relationship of inhibition data is reported. This nonradioactive assay affords detection levels of molecular phosphate released from a phosphorylated hexapeptide in subnanomolar quantities. The comparison of our IC50 values of these inhibitors against corresponding literature data provided validation for our method. (2) Computational analysis provided a global model for binding of these inhibitors to PP1. The natural toxins were shown to possess remarkably similar three-dimensional motifs upon superimposition and van der Waals minimization within the PP1 active site.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9379439     DOI: 10.1021/jm960873x

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  10 in total

1.  Cocaine and antidepressant-sensitive biogenic amine transporters exist in regulated complexes with protein phosphatase 2A.

Authors:  A L Bauman; S Apparsundaram; S Ramamoorthy; B E Wadzinski; R A Vaughan; R D Blakely
Journal:  J Neurosci       Date:  2000-10-15       Impact factor: 6.167

2.  Greatwall-phosphorylated Endosulfine is both an inhibitor and a substrate of PP2A-B55 heterotrimers.

Authors:  Byron C Williams; Joshua J Filter; Kristina A Blake-Hodek; Brian E Wadzinski; Nicholas J Fuda; David Shalloway; Michael L Goldberg
Journal:  Elife       Date:  2014-03-11       Impact factor: 8.140

3.  NHE3 function and phosphorylation are regulated by a calyculin A-sensitive phosphatase.

Authors:  Diane W Dynia; Amy G Steinmetz; Hetal S Kocinsky
Journal:  Am J Physiol Renal Physiol       Date:  2009-12-16

4.  Crystal structures of protein phosphatase-1 bound to nodularin-R and tautomycin: a novel scaffold for structure-based drug design of serine/threonine phosphatase inhibitors.

Authors:  Matthew S Kelker; Rebecca Page; Wolfgang Peti
Journal:  J Mol Biol       Date:  2008-11-01       Impact factor: 5.469

Review 5.  Calyculins and related marine natural products as serine-threonine protein phosphatase PP1 and PP2A inhibitors and total syntheses of calyculin A, B, and C.

Authors:  Annika E Fagerholm; Damien Habrant; Ari M P Koskinen
Journal:  Mar Drugs       Date:  2010-01-21       Impact factor: 5.118

6.  Functional characterization of ttmM unveils new tautomycin analogs and insight into tautomycin biosynthesis and activity.

Authors:  Jianhua Ju; Wenli Li; Qiuping Yuan; Noel R Peters; F Michael Hoffmann; Scott R Rajski; Hiroyuki Osada; Ben Shen
Journal:  Org Lett       Date:  2009-04-02       Impact factor: 6.005

7.  Abrogation of TGF-beta1-induced fibroblast-myofibroblast differentiation by histone deacetylase inhibition.

Authors:  Weichao Guo; Bin Shan; Ross C Klingsberg; Xiangmei Qin; Joseph A Lasky
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2009-08-21       Impact factor: 5.464

8.  Growth arrest and DNA damage-inducible protein GADD34 targets protein phosphatase 1 alpha to the endoplasmic reticulum and promotes dephosphorylation of the alpha subunit of eukaryotic translation initiation factor 2.

Authors:  Matthew H Brush; Douglas C Weiser; Shirish Shenolikar
Journal:  Mol Cell Biol       Date:  2003-02       Impact factor: 4.272

9.  Cellular serine/threonine phosphatase activity during human cytomegalovirus infection.

Authors:  Morgan Hakki; Adam P Geballe
Journal:  Virology       Date:  2008-08-30       Impact factor: 3.616

10.  Effects of a fluorescent Myosin light chain phosphatase inhibitor on prostate cancer cells.

Authors:  Scott Grindrod; Simeng Suy; Shannon Fallen; Masumi Eto; Jeffrey Toretsky; Milton L Brown
Journal:  Front Oncol       Date:  2011-09-20       Impact factor: 6.244

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.